The Ras-GTPase inhibitor, FPT inhibitor III, effectively blocked the activation of ERK1/2 and the expression of Snail as well as the wound healing rate in Tβ10-silenced CCA cell lines (M055-sh-Tβ10 and M214-sh-Tβ10). Here, MAPK3 is linked to cholangiocarcinoma.